Samsung Biologics has announced a new initiative to enhance its corporate culture with the goal of becoming a leading biopharmaceutical company by 2030. The initiative, known as "Samsung Biologics Way," was launched with a declaration ceremony, during which both management and employees committed to collaborating in order to foster a new company culture. This includes improving communication, fostering mutual respect, and encouraging employees to embrace new challenges. The company believes that this initiative will help create an inclusive and innovative culture, and has been preparing for it over the past three months through consultations with experts, employee surveys, workshops, and focus group interviews. As part of the new initiative, Samsung Biologics plans to focus on improving relations between management and workers, as well as enhancing training and educational programs for its employees. Additionally, the company aims to engage in corporate social responsibility activities and campaigns to promote the values of mutual respect. CEO John Rim emphasized that this declaration marks the first step in innovating the company's corporate culture, and that Samsung Biologics will continue its efforts to establish a culture that values and rewards its employees. In summary, Samsung Biologics has launched a comprehensive initiative, "Samsung Biologics Way," to revamp its corporate culture and aims to become a top-tier biopharmaceutical company by 2030. The company is committed to improving communication, fostering mutual respect, and encouraging employees to embrace new challenges. It has also outlined plans to enhance management-worker relations, provide more training and educational opportunities, and engage in corporate social responsibility activities. CEO John Rim has expressed the company's dedication to creating a culture that values and rewards its employees.